vs
Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $71.1M, roughly 1.5× RE/MAX Holdings, Inc.). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -4.7%).
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
IMCR vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $104.5M | $71.1M |
| Net Profit | — | $1.4M |
| Gross Margin | 97.4% | — |
| Operating Margin | -18.8% | 13.1% |
| Net Margin | — | 2.0% |
| Revenue YoY | 24.3% | -1.8% |
| Net Profit YoY | — | -75.2% |
| EPS (diluted) | $-0.61 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $104.5M | $71.1M | ||
| Q3 25 | $103.7M | $73.2M | ||
| Q2 25 | $98.0M | $72.8M | ||
| Q1 25 | $93.9M | $74.5M | ||
| Q4 24 | $84.1M | $72.5M | ||
| Q3 24 | $80.2M | $78.5M | ||
| Q2 24 | $75.4M | $78.5M | ||
| Q1 24 | $70.5M | $78.3M |
| Q4 25 | — | $1.4M | ||
| Q3 25 | $-177.0K | $4.0M | ||
| Q2 25 | $-10.3M | $4.7M | ||
| Q1 25 | $5.0M | $-2.0M | ||
| Q4 24 | — | $5.8M | ||
| Q3 24 | $8.7M | $966.0K | ||
| Q2 24 | $-11.6M | $3.7M | ||
| Q1 24 | $-24.4M | $-3.4M |
| Q4 25 | 97.4% | — | ||
| Q3 25 | 99.5% | — | ||
| Q2 25 | 98.9% | — | ||
| Q1 25 | 99.1% | — | ||
| Q4 24 | 99.6% | — | ||
| Q3 24 | 99.4% | — | ||
| Q2 24 | 97.7% | — | ||
| Q1 24 | 99.7% | — |
| Q4 25 | -18.8% | 13.1% | ||
| Q3 25 | -6.9% | 25.0% | ||
| Q2 25 | -15.2% | 19.3% | ||
| Q1 25 | -3.9% | 7.2% | ||
| Q4 24 | -23.1% | 5.9% | ||
| Q3 24 | -10.6% | 19.4% | ||
| Q2 24 | -21.2% | 20.6% | ||
| Q1 24 | -37.6% | 5.8% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | -0.2% | 5.4% | ||
| Q2 25 | -10.5% | 6.4% | ||
| Q1 25 | 5.4% | -2.6% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 10.9% | 1.2% | ||
| Q2 24 | -15.4% | 4.7% | ||
| Q1 24 | -34.7% | -4.3% |
| Q4 25 | $-0.61 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.20 | — | ||
| Q1 25 | $0.10 | — | ||
| Q4 24 | $-0.47 | — | ||
| Q3 24 | $0.17 | — | ||
| Q2 24 | $-0.23 | — | ||
| Q1 24 | $-0.49 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $864.2M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $381.0M | $452.4M |
| Total Assets | $1.1B | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $864.2M | $118.7M | ||
| Q3 25 | $892.4M | $107.5M | ||
| Q2 25 | $882.8M | $94.3M | ||
| Q1 25 | $837.0M | $89.1M | ||
| Q4 24 | $820.4M | $96.6M | ||
| Q3 24 | $901.3M | $83.8M | ||
| Q2 24 | $859.6M | $66.1M | ||
| Q1 24 | $832.8M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | $438.7M | $437.2M | ||
| Q2 24 | $452.5M | $438.1M | ||
| Q1 24 | $452.5M | $439.0M |
| Q4 25 | $381.0M | $452.4M | ||
| Q3 25 | $396.6M | $448.1M | ||
| Q2 25 | $388.5M | $442.4M | ||
| Q1 25 | $378.5M | $433.5M | ||
| Q4 24 | $360.7M | $429.5M | ||
| Q3 24 | $377.8M | $423.1M | ||
| Q2 24 | $359.1M | $418.4M | ||
| Q1 24 | $359.5M | $412.0M |
| Q4 25 | $1.1B | $582.5M | ||
| Q3 25 | $1.1B | $582.2M | ||
| Q2 25 | $1.1B | $574.8M | ||
| Q1 25 | $1.0B | $571.4M | ||
| Q4 24 | $1.0B | $581.6M | ||
| Q3 24 | $1.1B | $578.6M | ||
| Q2 24 | $1.0B | $571.4M | ||
| Q1 24 | $994.0M | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | 1.16× | 1.03× | ||
| Q2 24 | 1.26× | 1.05× | ||
| Q1 24 | 1.26× | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-32.7M | $40.9M |
| Free Cash FlowOCF − Capex | $-35.5M | $33.5M |
| FCF MarginFCF / Revenue | -34.0% | 47.1% |
| Capex IntensityCapex / Revenue | 2.8% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-15.1M | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-32.7M | $40.9M | ||
| Q3 25 | $-4.5M | $17.7M | ||
| Q2 25 | $26.0M | $4.6M | ||
| Q1 25 | $435.0K | $5.7M | ||
| Q4 24 | $-14.0M | $59.7M | ||
| Q3 24 | $21.1M | $17.6M | ||
| Q2 24 | $23.5M | $15.9M | ||
| Q1 24 | $-4.6M | $9.4M |
| Q4 25 | $-35.5M | $33.5M | ||
| Q3 25 | $-5.2M | $16.4M | ||
| Q2 25 | $25.6M | $2.9M | ||
| Q1 25 | $137.0K | $4.0M | ||
| Q4 24 | $-17.5M | $53.0M | ||
| Q3 24 | $20.3M | $16.3M | ||
| Q2 24 | $23.1M | $14.0M | ||
| Q1 24 | $-5.0M | $6.8M |
| Q4 25 | -34.0% | 47.1% | ||
| Q3 25 | -5.0% | 22.4% | ||
| Q2 25 | 26.1% | 4.0% | ||
| Q1 25 | 0.1% | 5.3% | ||
| Q4 24 | -20.9% | 73.2% | ||
| Q3 24 | 25.3% | 20.8% | ||
| Q2 24 | 30.7% | 17.8% | ||
| Q1 24 | -7.1% | 8.6% |
| Q4 25 | 2.8% | 10.4% | ||
| Q3 25 | 0.7% | 1.8% | ||
| Q2 25 | 0.4% | 2.2% | ||
| Q1 25 | 0.3% | 2.3% | ||
| Q4 24 | 4.3% | 9.1% | ||
| Q3 24 | 1.0% | 1.7% | ||
| Q2 24 | 0.4% | 2.4% | ||
| Q1 24 | 0.6% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | 2.42× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMCR
Segment breakdown not available.
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
